127 related articles for article (PubMed ID: 32152160)
1. Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: an observational, prospective study protocol.
Prieto M; Vicente-Vicente L; Casanova AG; Hernández-Sánchez MT; Gomez-Marcos MA; Garcia-Ortiz L; Morales AI;
BMJ Open; 2020 Mar; 10(3):e032918. PubMed ID: 32152160
[TBL] [Abstract][Full Text] [Related]
2. Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application.
Tascón J; Prieto M; Casanova AG; Sanz FJ; Hernández Mezquita MA; Barrueco Ferrero M; Gomez-Marcos MA; Garcia-Ortiz L; Vicente-Vicente L; Morales AI; On Behalf Of Biotab Team
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887529
[TBL] [Abstract][Full Text] [Related]
3. New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study.
Aguiar P; Azevedo O; Pinto R; Marino J; Baker R; Cardoso C; Ducla Soares JL; Hughes D
Mol Genet Metab; 2017 Jun; 121(2):162-169. PubMed ID: 28526293
[TBL] [Abstract][Full Text] [Related]
4. Association between different risk factors and vascular accelerated ageing (EVA study): study protocol for a cross-sectional, descriptive observational study.
Gomez-Marcos MA; Martinez-Salgado C; Gonzalez-Sarmiento R; Hernandez-Rivas JM; Sanchez-Fernandez PL; Recio-Rodriguez JI; Rodriguez-Sanchez E; García-Ortiz L
BMJ Open; 2016 Jun; 6(6):e011031. PubMed ID: 27267107
[TBL] [Abstract][Full Text] [Related]
5. Albuminuria Pre-Emptively Identifies Cardiac Patients at Risk of Contrast-Induced Nephropathy.
Vicente-Vicente L; Casanova AG; Hernández-Sánchez MT; Prieto M; Martínez-Salgado C; López-Hernández FJ; Cruz-González I; Morales AI
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768464
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke: study protocol for a randomized controlled trial.
Pita-Fernández S; Seijo-Bestilleiro R; Pértega-Díaz S; Alonso-Hernández Á; Fernández-Rivera C; Cao-López M; Seoane-Pillado T; López-Calviño B; González-Martín C; Valdés-Cañedo F
Trials; 2016 Apr; 17():174. PubMed ID: 27036112
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
[TBL] [Abstract][Full Text] [Related]
8. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
9. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P
Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007
[TBL] [Abstract][Full Text] [Related]
10. Validation of the automatic image analyser to assess retinal vessel calibre (ALTAIR): a prospective study protocol.
Garcia-Ortiz L; Gómez-Marcos MA; Recio-Rodríguez JI; Maderuelo-Fernández JA; Chamoso-Santos P; Rodríguez-González S; de Paz-Santana JF; Merchan-Cifuentes MA; Corchado-Rodríguez JM;
BMJ Open; 2014 Dec; 4(12):e006144. PubMed ID: 25468505
[TBL] [Abstract][Full Text] [Related]
11. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
12. Study protocol of a pragmatic, randomised controlled pilot trial: clinical effectiveness on smoking cessation of traditional and complementary medicine interventions, including acupuncture and aromatherapy, in combination with nicotine replacement therapy.
Jang S; Park S; Jang BH; Park YL; Lee JA; Cho CS; Go HY; Shin YC; Ko SG
BMJ Open; 2017 Jun; 7(5):e014574. PubMed ID: 28576892
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
14. Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol.
Liang S; Wang WL; Zhu FL; Duan SW; Sun XF; Chen XM; Cai GY;
BMJ Open; 2018 Feb; 8(2):e019457. PubMed ID: 29478020
[TBL] [Abstract][Full Text] [Related]
15. Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk - TIMER-): study protocol for a randomized controlled trial.
Jaén-Moreno MJ; Feu N; Redondo-Écija J; Montiel FJ; Gómez C; Del Pozo GI; Alcalá JÁ; Gutiérrez-Rojas L; Balanzá-Martinez V; Chauca GM; Carrión L; Osuna MI; Sánchez MD; Caro I; Ayora M; Valdivia F; López MS; Poyato JM; Sarramea F
Trials; 2019 Jan; 20(1):47. PubMed ID: 30642365
[TBL] [Abstract][Full Text] [Related]
16. The Moment Study: protocol for a mixed method observational cohort study of the Alternative Nicotine Delivery Systems (ANDS) initiation process among adult cigarette smokers.
Pearson JL; Smiley SL; Rubin LF; Anesetti-Rothermel A; Elmasry H; Davis M; DeAtley T; Harvey E; Kirchner T; Abrams DB
BMJ Open; 2016 Apr; 6(4):e011717. PubMed ID: 27105716
[TBL] [Abstract][Full Text] [Related]
17. Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension).
Gomez-Marcos MA; Gonzalez-Sarmiento R; Recio-Rodríguez JI; Agudo-Conde C; Gamella-Pozuelo L; Perretta-Tejedor N; Martínez-Salgado C; García-Ortiz L;
BMJ Open; 2014 Apr; 4(4):e005112. PubMed ID: 24699462
[TBL] [Abstract][Full Text] [Related]
18. Prospective longitudinal observational study of the macro and micro haemodynamic responses to septic shock in the renal and systemic circulations: a protocol for the MICROSHOCK - RENAL study.
Watchorn J; Huang D; Hopkins P; Bramham K; Hutchings S
BMJ Open; 2019 Aug; 9(8):e028364. PubMed ID: 31439601
[TBL] [Abstract][Full Text] [Related]
19. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease in children: Using novel biomarkers as predictors of disease.
Uwaezuoke SN; Ayuk AC; Muoneke VU; Mbanefo NR
Saudi J Kidney Dis Transpl; 2018; 29(4):775-784. PubMed ID: 30152412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
